Sales decline 15.77% to Rs 50.70 crore
Net profit of Hester Biosciences declined 68.21% to Rs 3.97 crore in the quarter ended June 2022 as against Rs 12.49 crore during the previous quarter ended June 2021. Sales declined 15.77% to Rs 50.70 crore in the quarter ended June 2022 as against Rs 60.19 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales50.7060.19 -16 OPM %14.6528.36 -PBDT10.5218.56 -43 PBT5.4615.33 -64 NP3.9712.49 -68Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
